← JBS overview

JBS vs Danone SA: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

JBS N.V. (JBS)

Q3 2026
▲3▼1

JBS expands with Indonesia cash, Pilgrim's buyout, and US beef opening

  • Indonesia sovereign fund invests $2.5B in JBS joint venture JBS formed a joint venture with an arm of Indonesia's sovereign wealth fund, which will invest $2.5 billion and house JBS's Australia and New Zealand businesses. This brings in fresh capital and expands JBS into Southeast Asian protein markets, supporting the stock.

    This is a major new capital and expansion event that directly boosts JBS's growth prospects.

  • Q2 earnings miss as profit falls JBS reported second-quarter earnings that missed expectations, with adjusted EBITDA down 8% and operating income down 16% from a year earlier. Even though revenue rose, weaker profitability pressures the stock because investors worry about margins.

    This is a new earnings report that directly affects how investors value JBS.

  • JBS bids for full control of Pilgrim's Pride in all-stock deal JBS proposed to buy the remaining 18% of Pilgrim's Pride it doesn't own, using JBS stock instead of cash. This would simplify the company, keep more cash flow, and remove Pilgrim's Pride from the Nasdaq. BofA called the deal attractive, lifting both stocks.

    This is a new strategic move that could streamline JBS and improve its financial flexibility.

  • US opens beef imports for 90 days to cool record prices President Trump lifted import quotas on ground beef for 90 days, allowing 300,000 metric tons without tariffs. As a major beef exporter, JBS can sell more into the US at a time of high prices, boosting demand for its products. Tyson Foods, a US competitor, is under pressure.

    This new policy directly increases demand for JBS's beef exports and improves its competitive position.

August 2026
▲3▼1

JBS expands with Indonesia cash, Pilgrim's buyout, and US beef opening

  • Indonesia sovereign fund invests $2.5B in JBS joint venture JBS formed a joint venture with an arm of Indonesia's sovereign wealth fund, which will invest $2.5 billion and house JBS's Australia and New Zealand businesses. This brings in fresh capital and expands JBS into Southeast Asian protein markets, supporting the stock.

    This is a major new capital and expansion event that directly boosts JBS's growth prospects.

  • Q2 earnings miss as profit falls JBS reported second-quarter earnings that missed expectations, with adjusted EBITDA down 8% and operating income down 16% from a year earlier. Even though revenue rose, weaker profitability pressures the stock because investors worry about margins.

    This is a new earnings report that directly affects how investors value JBS.

  • JBS bids for full control of Pilgrim's Pride in all-stock deal JBS proposed to buy the remaining 18% of Pilgrim's Pride it doesn't own, using JBS stock instead of cash. This would simplify the company, keep more cash flow, and remove Pilgrim's Pride from the Nasdaq. BofA called the deal attractive, lifting both stocks.

    This is a new strategic move that could streamline JBS and improve its financial flexibility.

  • US opens beef imports for 90 days to cool record prices President Trump lifted import quotas on ground beef for 90 days, allowing 300,000 metric tons without tariffs. As a major beef exporter, JBS can sell more into the US at a time of high prices, boosting demand for its products. Tyson Foods, a US competitor, is under pressure.

    This new policy directly increases demand for JBS's beef exports and improves its competitive position.

Latest
▲3▼1

JBS expands with Indonesia cash, Pilgrim's buyout, and US beef opening

  • Indonesia sovereign fund invests $2.5B in JBS joint venture JBS formed a joint venture with an arm of Indonesia's sovereign wealth fund, which will invest $2.5 billion and house JBS's Australia and New Zealand businesses. This brings in fresh capital and expands JBS into Southeast Asian protein markets, supporting the stock.

    This is a major new capital and expansion event that directly boosts JBS's growth prospects.

  • Q2 earnings miss as profit falls JBS reported second-quarter earnings that missed expectations, with adjusted EBITDA down 8% and operating income down 16% from a year earlier. Even though revenue rose, weaker profitability pressures the stock because investors worry about margins.

    This is a new earnings report that directly affects how investors value JBS.

  • JBS bids for full control of Pilgrim's Pride in all-stock deal JBS proposed to buy the remaining 18% of Pilgrim's Pride it doesn't own, using JBS stock instead of cash. This would simplify the company, keep more cash flow, and remove Pilgrim's Pride from the Nasdaq. BofA called the deal attractive, lifting both stocks.

    This is a new strategic move that could streamline JBS and improve its financial flexibility.

  • US opens beef imports for 90 days to cool record prices President Trump lifted import quotas on ground beef for 90 days, allowing 300,000 metric tons without tariffs. As a major beef exporter, JBS can sell more into the US at a time of high prices, boosting demand for its products. Tyson Foods, a US competitor, is under pressure.

    This new policy directly increases demand for JBS's beef exports and improves its competitive position.

Danone SA (BN.PA)

Q3 2026
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.

July 2026
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.

Latest
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.

© 2026 MarketIVWhy